Literature DB >> 8279865

[Plasmodium prevalence and parasitic burden in blood donors of Brazzaville, Congo].

B Carme1, D Kenmogne, N Copin, A Mbitsi.   

Abstract

To assess the frequency of malaria-infected blood donations in Brazzaville (Congo) thick films from all blood donors (n = 12,375, minimum per month: 857, maximum per month: 1,295; sex ratio: 9.6) at the Brazzaville University Hospital were examined quantitatively for Plasmodium (screening threshold: 20/microliters of blood) over one year (1989). The overall prevalence rate for all species of Plasmodium was 8.5%. It varied according with age but not with sex. P. falciparum predominated (92%), followed by P. malariae (7%) and P. ovale (3%). For P. falciparum: 1--the prevalence rate was 7.8% but varied over the year from 4.8% in August (6.2% for the dry season on the whole) to 11.5% in March (9.6% for the rainy season); 2--the parasitic load, also variable according to the season, was over 600/microliters in 24% of the cases (i.e. 1.9% of all donations) and over 6,000/microliters in 15 cases (i.e. 1.6% of the cases). In conclusion the proportion of blood donations infected with P. falciparum (with a parasitic load > or = 20/microliters) varied in Brazzaville from 6% in the dry season to 10% in the rainy season.

Entities:  

Mesh:

Year:  1993        PMID: 8279865

Source DB:  PubMed          Journal:  Ann Soc Belg Med Trop        ISSN: 0772-4128


  2 in total

1.  Impact of inconsistent policies for transfusion-transmitted malaria on clinical practice in Ghana.

Authors:  Alex K Owusu-Ofori; Imelda Bates
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

2.  Is a Plasmodium lactate dehydrogenase (pLDH) enzyme-linked immunosorbent (ELISA)-based assay a valid tool for detecting risky malaria blood donations in Africa?

Authors:  Pascal S Atchade; Cécile Doderer-Lang; Nicodème Chabi; Sylvie Perrotey; Tamer Abdelrahman; Casimir D Akpovi; Ludovic Anani; André Bigot; Ambaliou Sanni; Ermanno Candolfi
Journal:  Malar J       Date:  2013-08-08       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.